ワクチン研究開発拠点

我が国のワクチン発祥の地、
長崎から新たに始まるワクチン開発研究

Topics

ワクチン研究開発拠点について

長崎大学感染症研究出島特区ワクチン研究開発拠点は，「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」に採択された4つのシナジー拠点の一つです。長崎大学がこれまで研究してきた高病原性病原体や熱帯性病原体を対象としたワクチン開発を推進し，人類の脅威となる感染症に対するワクチン開発を目指します。

Careers

公募・求人情報

現在募集中の公募・求人情報はありません。

Publications

研究業績

%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22DNGWDHDT%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kim%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKim%2C%20C.%2C%20Frost%2C%20I.%2C%20Naylor%2C%20N.%20R.%2C%20Au%2C%20H.%2C%20Kim%2C%20Y.%2C%20Lee%2C%20Y.%2C%20Bzymek%2C%20A.%2C%20Majgier%2C%20K.%2C%20Moldoveanu%2C%20A.%20L.%2C%20Salman%2C%20O.%20M.%2C%20Simiyu%2C%20S.%2C%20Youssef%2C%20D.%20M.%2C%20Hasso-Agopsowicz%2C%20M.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282025%29.%20Length%20of%20hospital%20stay%20and%20associated%20treatment%20costs%20for%20patients%20with%20susceptible%20and%20antibiotic-resistant%20Salmonella%20infections%3A%20a%20systematic%20review%20and%20meta-analysis.%20%3Ci%3EBMJ%20Open%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%286%29%2C%20e092494.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-092494%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-092494%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Length%20of%20hospital%20stay%20and%20associated%20treatment%20costs%20for%20patients%20with%20susceptible%20and%20antibiotic-resistant%20Salmonella%20infections%3A%20a%20systematic%20review%20and%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chaelin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Frost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nichola%20R%22%2C%22lastName%22%3A%22Naylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%22%2C%22lastName%22%3A%22Au%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yeonhee%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yubin%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Bzymek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamila%22%2C%22lastName%22%3A%22Majgier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Laura%22%2C%22lastName%22%3A%22Moldoveanu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%20Mukhtar%22%2C%22lastName%22%3A%22Salman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shillah%22%2C%22lastName%22%3A%22Simiyu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dina%20Mohamed%22%2C%22lastName%22%3A%22Youssef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateusz%22%2C%22lastName%22%3A%22Hasso-Agopsowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cnnull%5Cn%5CnObjectives%5CnThe%20global%20disease%20burden%20of%20Salmonella%20infections%20in%202017%20included%20135%5Cu2009900%20deaths%20caused%20by%20Salmonella%20Typhi%20and%20Paratyphi%20and%2077%5Cu2009500%20deaths%20caused%20by%20invasive%20non-typhoidal%20Salmonella%2C%20with%20increasing%20antimicrobial%20resistance%20%28AMR%29%20exacerbating%20morbidity%2C%20mortality%20and%20costs.%20The%20aim%20of%20our%20systematic%20review%20and%20meta-analysis%20is%20to%20estimate%20the%20length%20of%20hospital%20stay%20and%20associated%20treatment%20costs%20for%20patients%20with%20susceptible%20and%20antibiotic-resistant%20Salmonella%20Typhi%2C%20Paratyphi%20and%20non-typhoidal%20Salmonella%20infections.%5Cn%5CnDesign%5CnSystematic%20review%20and%20meta-analysis.%5Cn%5CnData%20sources%5CnWe%20searched%20EMBASE%2C%20Medline%5C%2FPubMed%2C%20Scopus%2C%20Hinari%20and%20LILACS%20databases%20for%20studies%20published%20between%201%20January%202005%20and%2015%20May%202024%2C%20with%20no%20language%20restrictions.%5Cn%5CnEligibility%20criteria%5CnWe%20included%2030%20studies%20that%20reported%20the%20length%20of%20hospital%20stay%20or%20treatment%20costs%20for%20patients%20with%20susceptible%20or%20antibiotic-resistant%20Salmonella%20Typhi%2C%20Paratyphi%20and%20non-typhoidal%20Salmonella%20infections.%20We%20excluded%20studies%20with%20sample%20sizes%20of%20less%20than%2030%20patients%2C%20those%20focused%20on%20non-human%20subjects%20and%20those%20not%20reporting%20our%20outcomes%20of%20interest.%5Cn%5CnData%20extraction%20and%20synthesis%5CnTwo%20reviewers%20independently%20screened%20studies%20and%20extracted%20data%20on%20the%20length%20of%20hospital%20stay%20and%20associated%20costs%2C%20with%20monetary%20values%20converted%20to%202019%20USD.%20We%20aggregated%20data%20according%20to%20GDP%20per%20capita%20quantiles%20using%20a%20random-effects%20meta-analysis.%20We%20conducted%20a%20quality%20assessment%20using%20an%20adapted%20Joanna%20Briggs%20Institute%20tool.%5Cn%5CnResults%5CnPatients%20with%20drug-resistant%20Salmonella%20infections%20had%20longer%20hospital%20stays%2C%20with%20an%20additional%200.5%5Cu20132.2%5Cu2009days%20compared%20with%20drug-susceptible%20Salmonella%20infections.%20Based%20on%20our%20meta-analysis%2C%20the%20mean%20hospital%20stay%20for%20typhoidal%20Salmonella%20infections%20was%206.4%5Cu2009days%20%2895%25%5Cu2009CI%204.9%20to%207.8%29%20for%20drug-susceptible%20cases%20and%208.4%5Cu2009days%20%2895%25%5Cu2009CI%205.1%20to%2011.7%29%20for%20resistant%20cases%20in%20the%20lowest%20income%20quartiles.%20While%20there%20were%20insufficient%20data%20to%20perform%20a%20pooled%20analysis%2C%20individual%20studies%20inferred%20that%20treatment%20costs%20for%20resistant%20typhoidal%20Salmonella%20infections%20were%20higher%20than%20for%20susceptible%20infections%2C%20and%20resistant%20non-typhoidal%20Salmonella%20infections%20had%20longer%20hospital%20stays%20and%20higher%20costs%20compared%20with%20susceptible%20infections.%20Data%20were%20scarce%20from%20high-Salmonella-burden%20countries%2C%20particularly%20in%20sub-Saharan%20Africa%20and%20parts%20of%20Asia.%5Cn%5CnConclusions%5CnPatients%20with%20antibiotic-resistant%20Salmonella%20infections%20experience%20a%20greater%20healthcare%20burden%20in%20terms%20of%20hospitalisation%20length%20and%20direct%20costs%20compared%20with%20those%20with%20susceptible%20infections.%20We%20highlight%20the%20economic%20burden%20of%20AMR%20in%20Salmonella%20infections%20and%20emphasise%20the%20need%20for%20preventive%20measures.%22%2C%22date%22%3A%222025-6-23%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2024-092494%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC12186044%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-07-01T03%3A00%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22CVRUH3EE%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Naylor%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENaylor%2C%20N.%20R.%2C%20Hasso-Agopsowicz%2C%20M.%2C%20Kim%2C%20C.%2C%20Ma%2C%20Y.%2C%20Frost%2C%20I.%2C%20Abbas%2C%20K.%2C%20Aguilar%2C%20G.%2C%20Fuller%2C%20N.%2C%20Robotham%2C%20J.%20V.%2C%20%26amp%3B%20Jit%2C%20M.%20%282025%29.%20The%20global%20economic%20burden%20of%20antibiotic-resistant%20infections%20and%20the%20potential%20impact%20of%20bacterial%20vaccines%3A%20a%20modelling%20study.%20%3Ci%3EBMJ%20Global%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%286%29.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-016249%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-016249%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20global%20economic%20burden%20of%20antibiotic-resistant%20infections%20and%20the%20potential%20impact%20of%20bacterial%20vaccines%3A%20a%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nichola%20R.%22%2C%22lastName%22%3A%22Naylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateusz%22%2C%22lastName%22%3A%22Hasso-Agopsowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chaelin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yixuan%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Frost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gisela%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Fuller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20V.%22%2C%22lastName%22%3A%22Robotham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%20Antibiotic%20resistance%20%28ABR%29%20may%20increase%20hospital%20costs%2C%20utility%20loss%20and%20mortality%20risk%20per%20patient.%20Understanding%20these%20losses%20at%20national%2C%20regional%20and%20global%20scales%20is%20necessary%20for%20efficiently%20tackling%20ABR.%20Our%20aim%20is%20to%20estimate%20the%20global%20economic%20burden%20of%20antibiotic-resistant%20infections%20and%20the%20potential%20for%20bacterial%20vaccines%20to%20mitigate%20this%20burden.Methods%20We%20take%20healthcare%20system%20and%20labour%20productivity%20perspectives.%20Hospital%20cost-per-case%20and%20length-of-stay%20estimates%20were%20calculated%20through%20meta-analyses%20and%20reviewing%20published%20systematic%20reviews.%20Unit%20labour%20productivity%20losses%20were%20estimated%20through%20a%20human%20capital%20approach.%20Modelled%20estimates%20were%20used%20where%20secondary%20data%20were%20missing.%20Death%20and%20incidence%20data%20were%20combined%20with%20unit%20cost%20data%20to%20estimate%20the%20economic%20burden%20associated%20with%20ABR%20in%202019%2C%20and%20the%20potential%20costs%20averted%20%28in%202019%20US%24%29%20based%20on%20uptake%20scenarios%20of%20vaccines%20that%20currently%20exist%20or%20are%20likely%20to%20be%20developed.Results%20Multidrug-resistant%20tuberculosis%20had%20the%20highest%20mean%20hospital%20cost%20attributable%20to%20ABR%20per%20patient%2C%20the%20range%20was%20US%243000%20in%20lower-income%20settings%20to%20US%2441%20000%20in%20high-income%20settings%2C%20with%20carbapenem-resistant%20infections%20associated%20with%20a%20high%20cost-per-case%20of%20US%243000%5Cu2013US%247000%20depending%20on%20syndrome.%20ABR%20was%20associated%20with%20a%20median%20value%20of%20US%24693%20billion%20%28IQR%3A%20US%24627%20bn%5Cu2013US%24768%20bn%29%20in%20hospital%20costs%20globally%2C%20with%20US%24207%20bn%20%28IQR%3A%20US%24186%20bn%5Cu2013US%24229%20bn%29%20potentially%20avertable%20by%20vaccines.%20Productivity%20losses%20were%20quantified%20at%20almost%20US%24194%20billion%2C%20with%20US%2476%20bn%20avertable%20by%20vaccines.Conclusions%20The%20economic%20burden%20of%20ABR%20is%20associated%20with%20high%20levels%20of%20hospital%20bed-days%20occupied%2C%20hospital%20spending%20and%20labour%20productivity%20losses%20globally%20and%20should%2C%20therefore%2C%20remain%20high%20on%20national%20and%20international%20policy%20agendas.%20Vaccines%20against%20Staphylococcus%20aureus%2C%20Escherichia%20coli%20and%20Klebsiella%20pneumoniae%20would%20avert%20a%20substantial%20portion%20of%20the%20economic%20burden%20associated%20with%20ABR.%20More%20robust%20evidence%2C%20particularly%20in%20low-income%20countries%2C%20on%20the%20hospital%20costs%2C%20associated%20with%20and%20attributable%20to%20ABR%2C%20is%20needed.%22%2C%22date%22%3A%222025-06-19%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2024-016249%22%2C%22ISSN%22%3A%222059-7908%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fgh.bmj.com%5C%2Fcontent%5C%2F10%5C%2F6%5C%2Fe016249%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-07-01T02%3A59%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22H4VT5KQF%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWang%2C%20C.%2C%20Lai%2C%20X.%2C%20Abbas%2C%20K.%2C%20Pouwels%2C%20K.%20B.%2C%20Zhang%2C%20H.%2C%20Jit%2C%20M.%2C%20%26amp%3B%20Fang%2C%20H.%20%282025%29.%20Health%20impact%20and%20economic%20evaluation%20of%20the%20Expanded%20Program%20on%20Immunization%20in%20China%20from%201974%20to%202024%3A%20a%20modelling%20study.%20%3Ci%3EThe%20Lancet%20Public%20Health%3C%5C%2Fi%3E%2C%20S2468266725000398.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2468-2667%2825%2900039-8%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2468-2667%2825%2900039-8%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Health%20impact%20and%20economic%20evaluation%20of%20the%20Expanded%20Program%20on%20Immunization%20in%20China%20from%201974%20to%202024%3A%20a%20modelling%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chaofan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaozhen%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koen%20B%22%2C%22lastName%22%3A%22Pouwels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haijun%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Jit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hai%22%2C%22lastName%22%3A%22Fang%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-04-23%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS2468-2667%2825%2900039-8%22%2C%22ISSN%22%3A%2224682667%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2468266725000398%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-01T03%3A25%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22LJ65XF52%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Mutua%2C%20M.%20M.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Kaneko%2C%20S.%2C%20Urano%2C%20T.%2C%20Muthugala%2C%20R.%2C%20Fernando%2C%20L.%2C%20Hapugoda%2C%20M.%2C%20Gunawardene%2C%20Y.%2C%20%26amp%3B%20Morita%2C%20K.%20%282025%29.%20Molecular%20and%20serological%20evidence%20of%20chikungunya%20virus%20among%20dengue%20suspected%20patients%20in%20Sri%20Lanka.%20%3Ci%3EJournal%20of%20Infection%20and%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E18%3C%5C%2Fi%3E%285%29%2C%20102709.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2025.102709%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2025.102709%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20and%20serological%20evidence%20of%20chikungunya%20virus%20among%20dengue%20suspected%20patients%20in%20Sri%20Lanka%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurine%20Mumo%22%2C%22lastName%22%3A%22Mutua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Kaneko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohitha%22%2C%22lastName%22%3A%22Muthugala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakkumar%22%2C%22lastName%22%3A%22Fernando%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Menaka%22%2C%22lastName%22%3A%22Hapugoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yins%22%2C%22lastName%22%3A%22Gunawardene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-03-10%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jiph.2025.102709%22%2C%22ISSN%22%3A%2218760341%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1876034125000589%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-04-09T02%3A45%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22RDHWQE4A%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bharati%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBharati%2C%20N.%2C%20Dumre%2C%20S.%20P.%2C%20Shah%2C%20Y.%2C%20Nabesima%2C%20T.%2C%20Dhimal%2C%20M.%2C%20Pandey%2C%20S.%2C%20Kapandji%2C%20M.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Pandey%2C%20B.%20D.%2C%20Morita%2C%20K.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20%26amp%3B%20Pandey%2C%20K.%20%282024%29.%20Circulating%20serotypes%20and%20genotypes%20of%20dengue%20virus%20during%20the%202023%20outbreak%20in%20Eastern%20Nepal.%20%3Ci%3EJournal%20of%20Clinical%20Virology%3C%5C%2Fi%3E%2C%20%3Ci%3E174%3C%5C%2Fi%3E%2C%20105721.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcv.2024.105721%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcv.2024.105721%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Circulating%20serotypes%20and%20genotypes%20of%20dengue%20virus%20during%20the%202023%20outbreak%20in%20Eastern%20Nepal%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niten%22%2C%22lastName%22%3A%22Bharati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yogendra%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Nabesima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meghnath%22%2C%22lastName%22%3A%22Dhimal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srijana%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merveille%22%2C%22lastName%22%3A%22Kapandji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kishor%22%2C%22lastName%22%3A%22Pandey%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-09-03%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcv.2024.105721%22%2C%22ISSN%22%3A%2213866532%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1386653224000830%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-04-09T02%3A39%3A25Z%22%7D%7D%5D%7D

Kim, C., Frost, I., Naylor, N. R., Au, H., Kim, Y., Lee, Y., Bzymek, A., Majgier, K., Moldoveanu, A. L., Salman, O. M., Simiyu, S., Youssef, D. M., Hasso-Agopsowicz, M., & Abbas, K. (2025). Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: a systematic review and meta-analysis. BMJ Open, 15(6), e092494. https://doi.org/10.1136/bmjopen-2024-092494

Naylor, N. R., Hasso-Agopsowicz, M., Kim, C., Ma, Y., Frost, I., Abbas, K., Aguilar, G., Fuller, N., Robotham, J. V., & Jit, M. (2025). The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study. BMJ Global Health, 10(6). https://doi.org/10.1136/bmjgh-2024-016249

Wang, C., Lai, X., Abbas, K., Pouwels, K. B., Zhang, H., Jit, M., & Fang, H. (2025). Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study. The Lancet Public Health, S2468266725000398. https://doi.org/10.1016/S2468-2667(25)00039-8

Ngwe Tun, M. M., Mutua, M. M., Inoue, S., Takamatsu, Y., Kaneko, S., Urano, T., Muthugala, R., Fernando, L., Hapugoda, M., Gunawardene, Y., & Morita, K. (2025). Molecular and serological evidence of chikungunya virus among dengue suspected patients in Sri Lanka. Journal of Infection and Public Health, 18(5), 102709. https://doi.org/10.1016/j.jiph.2025.102709

Bharati, N., Dumre, S. P., Shah, Y., Nabesima, T., Dhimal, M., Pandey, S., Kapandji, M., Takamatsu, Y., Urano, T., Pandey, B. D., Morita, K., Ngwe Tun, M. M., & Pandey, K. (2024). Circulating serotypes and genotypes of dengue virus during the 2023 outbreak in Eastern Nepal. Journal of Clinical Virology, 174, 105721. https://doi.org/10.1016/j.jcv.2024.105721

View all

長崎大学感染症研究出島特区
ワクチン研究開発拠点

新着情報

感染症疫学チーム「Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: a systematic review and meta-analysis」を発表 2025/6/23

感染症疫学チーム「The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study」を発表 2025/6/19

短期コース＆シンポジウム”Vaccinology: Science and Public Health 2025″の開催について

サマーコース”Introduction to Infectious Disease Epidemiology and Modelling”の開催について

感染症疫学チーム「Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study」を発表 2025/4/23

感染症疫学チーム「Is Southeast Asia and the Western Pacific ready for potential monkeypox virus outbreaks?」を発表 2025/3/29

感染症疫学チーム「Phylogenetic Study of Local Patterns Influenza A(H3N2)Virus Transmission in a Semi-Isolated Population ina Remote Island in Japan Between 2011 and 2013」を発表 2025/3/10

感染症疫学チーム「Potential Health Impact and Cost-Effectiveness of Human Papillo- Mavirus Vaccination in Tunisia: A Comparative Modeling Study」を発表 2025/3/27

感染症疫学チーム：「Vaccination strategies against wild poliomyelitis in polio- free settings」を発表 2025/3/22

VRDCニュースレター創刊号（Vol.1）を発行いたしました

Bio Japan 2024 へ出展しました！

ワクチン学シンポジウムおよび短期コースを開催しました

VRDCニュースレター創刊号（Vol.1）を発行いたしました

Bio Japan 2024 へ出展しました！

ワクチン学シンポジウムおよび短期コースを開催しました

長崎大学感染症研究出島特区ワクチン研究開発拠点のウェブページを公開しました。

短期コース＆シンポジウム”Vaccinology: Science and Public Health 2025″の開催について

サマーコース”Introduction to Infectious Disease Epidemiology and Modelling”の開催について

BioJapan 2024に出展します！

「ワクチン学シンポジウム：サイエンスと公衆衛生をつなぐ」の開催について

ワクチン学短期コースの実施について

トレーニングコースの開催について

“7月6日はワクチンの日” 市民公開講座「ワクチン今昔物語～研究者の生のはなしを聞いてみよう～」開催！

シンポジウムの開催について

感染症疫学短期コース “Introduction to Infectious Disease Epidemiology and Modelling” を開催しました